Oxford BioDynamics Plc
OBD.L · LSE
9/30/2025 | 9/30/2024 | 9/30/2023 | 9/30/2022 | |
|---|---|---|---|---|
| Market Cap | £6,589 | £8,234 | £54,568 | £11,466 |
| - Cash | £1,392 | £1,827 | £5,250 | £974 |
| + Debt | £5,111 | £5,740 | £6,439 | £6,136 |
| Enterprise Value | £10,308 | £12,147 | £55,757 | £16,628 |
| Revenue | £1,095 | £636 | £510 | £154 |
| % Growth | 72.2% | 24.7% | 231.2% | – |
| Gross Profit | -£6,149 | £289 | £266 | £116 |
| % Margin | -561.6% | 45.4% | 52.2% | 75.3% |
| EBITDA | -£9,801 | -£10,265 | -£9,841 | -£6,159 |
| % Margin | -895.1% | -1,614% | -1,929.6% | -3,999.4% |
| Net Income | -£11,153 | -£11,567 | -£10,826 | -£6,710 |
| % Margin | -1,018.5% | -1,818.7% | -2,122.7% | -4,357.1% |
| EPS Diluted | -0.008 | -0.045 | -0.073 | -0.067 |
| % Growth | 82.3% | 38.4% | -9.1% | – |
| Operating Cash Flow | -£7,709 | -£10,172 | -£8,294 | -£5,177 |
| Capital Expenditures | -£17 | -£595 | -£716 | -£901 |
| Free Cash Flow | -£7,726 | -£10,767 | -£9,010 | -£6,078 |